Evidence map›Paper›PMID 32634813›Full record

ArticleCerebrovascular diseases (Basel, Switzerland)2020

COVID-19 and Stroke: Casual or Causal Role?

Carlo Emanuele Saggese, Chiara Del Bianco, Maria Rita Di Ruzza, Maria Magarelli, Roberto Gandini, Maurizio Plocco

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Cerebrovascular diseases (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. COVID-19: Neuroimaging Features of a Pandemic.Journal of neuroimaging : official journal of the American Society of Neuroimaging · 2021
    Review
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Carlo Emanuele SaggeseUTN (Neurovascular Therapy Unit), F. Spaziani Hospital, Frosinone, Italy, emanuele.saggese@aslfrosinone.it.
Chiara Del BiancoUTN (Neurovascular Therapy Unit), F. Spaziani Hospital, Frosinone, Italy.
Maria Rita Di RuzzaUTN (Neurovascular Therapy Unit), F. Spaziani Hospital, Frosinone, Italy.
Maria MagarelliUTN (Neurovascular Therapy Unit), F. Spaziani Hospital, Frosinone, Italy.
Roberto GandiniInterventional Radiology, Policlinico Tor Vergata (PTV), Rome, Italy.
Maurizio PloccoUTN (Neurovascular Therapy Unit), F. Spaziani Hospital, Frosinone, Italy.
Policlinico Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe COVID-19 outbreak is currently the major public health concern worldwide. This infection, caused by the novel coronavirus Sars Cov2, primarily affects respiratory system, but there is increasing evidence of neurologic involvement and cerebrovascular accidents. CASE REPORT: We present a case of stroke in a 62-year-old COVID-19-positive patient, with multiple vascular risk factors. The patient arrived 1 h after onset of symptoms, was treated with recombinant tissue plasminogen activator (rtPA) with improvement of neurologic deficits, and later developed right foot arterial ischemia (recanalized by balloon catheter angioplasty) and left arm superficial venous thrombosis. A control computed tomography (CT) scan 7 days after onset showed hemorrhagic transformation of ischemic lesion without mass effect. However, respiratory and neurologic conditions improved so that the patient was discharged to rehabilitation. DISCUSSION: Until now, few cases of stroke in COVID-19 have been described, mainly in severe forms. This patient had ischemic injuries in different sites as well as venous thrombosis; hence, we speculate that Sars Cov2 could have a direct role in promoting vascular accidents since its receptor ACE2 is a surface protein also expressed by endothelial cells. This case suggests that COVID-19 can favor strokes and in general vascular complications, even in milder cases, and the presence of preexisting risk factors could play a determinant role.

Indexed as

CausalityCerebrovascular DisordersCoronavirus InfectionsCOVID-19HumansLungMaleMiddle AgedPandemicsPneumonia, ViralRisk FactorsStrokeThrombolytic TherapyTissue Plasminogen ActivatorTomography, X-Ray ComputedTissue Plasminogen ActivatorAcute stroke managementAcute stroke thrombolysisAngioplastyCOVID-19

Identifiers

PMID32634813
PMCPMC7445378
OpenAlexW3040997673

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.